Tugce Kubra Gunes

4PUBLICATIONS
97CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

|May 20, 2025
Extraordinary Benefit of Regorafenib in Metastatic Cholangiocarcinoma: A Case Report.

Ayberk Bayramgil, Tugce Kubra Gunes, Fatma Gulcicek Ayranci

Pageof 1

Frequent Collaborators

2 joint publications

Gökhan Şahin

2 joint publications

Salih Tunbekici

2 joint publications

Halil Goksel Guzel

2 joint publications

Kursat Dıslı